Abstract：
BACKGROUND: Aetiology for non-closure of full-thickness macular hole (FTMH) becomes crucial in determining the method of effective mode of intervention. Association of epiretinal proliferation (ERP) along with full-thickness macular hole (FTMH) have shown poorer anatomic and visual outcomes after surgical intervention. Various surgical techniques have been described in literature for treatment of persistent MH.
METHODS: We report a A 60-year-old female patient with FTMH secondary to branched retinal vein occlusion (BRVO) initially associated with ERP.
METHODS: She was successfully managed by treating with combination of intravitreal injection of off label bevacizumab (Avastin) (1.25 mg/0.05 ml) and pure gas of SF6 (1 cc) under topical anaesthesia after an initial surgical intervention.
CONCLUSIONS: Presence of ERP in retinal vein occlusion cases needs closer and frequent follow up. IVB can be used as an adjunct in treating secondary MH.
METHODS: We report a A 60-year-old female patient with FTMH secondary to branched retinal vein occlusion (BRVO) initially associated with ERP.
METHODS: She was successfully managed by treating with combination of intravitreal injection of off label bevacizumab (Avastin) (1.25 mg/0.05 ml) and pure gas of SF6 (1 cc) under topical anaesthesia after an initial surgical intervention.
CONCLUSIONS: Presence of ERP in retinal vein occlusion cases needs closer and frequent follow up. IVB can be used as an adjunct in treating secondary MH.
摘要：
背景：全厚度黄斑裂孔（FTMH）非闭合的病因在确定有效干预方式方面至关重要。视网膜上增生（ERP）与全厚度黄斑裂孔（FTMH）的关联在手术干预后显示出较差的解剖和视觉结果。文献中已经描述了用于治疗持续性MH的各种外科技术。
方法：我们报告了一名60岁的女性FTMH患者，继发于视网膜分支静脉阻塞（BRVO），最初与ERP相关。
方法：在初次手术干预后，在局部麻醉下，玻璃体内注射脱标贝伐单抗（阿瓦斯汀）（1.25mg/0.05ml）和SF6纯气体（1cc）联合治疗，成功治疗。
结论：视网膜静脉阻塞病例中存在ERP需要密切和频繁的随访。IVB可用作治疗继发性MH的辅助手段。
方法：我们报告了一名60岁的女性FTMH患者，继发于视网膜分支静脉阻塞（BRVO），最初与ERP相关。
方法：在初次手术干预后，在局部麻醉下，玻璃体内注射脱标贝伐单抗（阿瓦斯汀）（1.25mg/0.05ml）和SF6纯气体（1cc）联合治疗，成功治疗。
结论：视网膜静脉阻塞病例中存在ERP需要密切和频繁的随访。IVB可用作治疗继发性MH的辅助手段。
